Immunocore Holdings (Immunocore Holdings) Interest Expense : $-8.5 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Immunocore Holdings's interest expense for the three months ended in Mar. 2024 was $ -4.1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-8.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Immunocore Holdings's Operating Income for the three months ended in Mar. 2024 was $ -33.7 Mil. Immunocore Holdings's Interest Expense for the three months ended in Mar. 2024 was $ -4.1 Mil. Immunocore Holdings did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Immunocore Holdings Interest Expense Historical Data

The historical data trend for Immunocore Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Interest Expense Chart

Immunocore Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-4.98

-4.18

-7.41

-6.59

-6.52

Immunocore Holdings Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-1.52	-1.98	-2.02	-0.43	-4.12

Immunocore Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.5 Mil.

Immunocore Holdings (NAS:IMCR) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Immunocore Holdings's Interest Expense for the three months ended in Mar. 2024 was $-4.1 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-33.7 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $599.1 Mil.

Immunocore Holdings's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Immunocore Holdings did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

6YG:Germany 6YG:Germany

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.